Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.410
+0.050 (3.68%)
May 29, 2026, 4:00 PM EDT - Market closed

APUS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.98-6-1.39-0.78-0.67-1.03
Depreciation & Amortization
0.020.01----
Stock-Based Compensation
8.543.27-0.070.190.19
Other Adjustments
22.11-3.370.120.040.030.01
Changes in Accounts Payable
-0.02-0.410.540.05-00
Changes in Other Operating Activities
-4.32-2.410-0.010-0
Operating Cash Flow
-11.24-8.93-0.73-0.63-0.45-0.82
Capital Expenditures
-0.07-0.06----
Purchases of Investments
0.5-2----
Payments for Business Acquisitions
-0.02----
Other Investing Activities
--8.02----
Investing Cash Flow
-5.07-10.06----
Long-Term Debt Issued
0.2710.280.330.010.280.4
Long-Term Debt Repaid
-0.13-0.34--0.03--
Net Long-Term Debt Issued (Repaid)
0.159.940.33-0.020.280.4
Issuance of Common Stock
-0.1611.63-1.06--
Net Common Stock Issued (Repurchased)
-0.1611.63-1.06--
Other Financing Activities
-0.08-0.95----
Financing Cash Flow
28.2320.620.331.030.280.4
Net Cash Flow
11.921.63-0.410.4-0.17-0.42
Free Cash Flow
-11.31-8.98-0.73-0.63-0.45-0.82
Free Cash Flow Per Share
-0.89-0.83-0.09-0.14-0.12-0.21
Levered Free Cash Flow
-45.221.06-0.52-0.76-0.39-0.62
Unlevered Free Cash Flow
-25.53-14.79-0.74-0.71-0.64-1.02
SEC Filings: 10-K · 10-Q